25 XP   0   0   10

BioForce Nanosciences Holdings Inc
Buy, Hold or Sell?

Let's analyse BioForce Nanosciences Holdings Inc together

PenkeI guess you are interested in BioForce Nanosciences Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioForce Nanosciences Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BioForce Nanosciences Holdings Inc

I send you an email if I find something interesting about BioForce Nanosciences Holdings Inc.

Quick analysis of BioForce Nanosciences Holdings Inc (30 sec.)










What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.07
Expected worth in 1 year
$-0.08
How sure are you?
19.4%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-1.5%

For what price can you sell your share?

Current Price per Share
$1.10
Expected price per share
$0.95 - $1.19
How sure are you?
50%

1. Valuation of BioForce Nanosciences Holdings Inc (5 min.)




Live pricePrice per Share (EOD)

$1.10

Intrinsic Value Per Share

$0.01 - $0.01

Total Value Per Share

$-0.06 - $-0.06

2. Growth of BioForce Nanosciences Holdings Inc (5 min.)




Is BioForce Nanosciences Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.9m-$1.2m-$474.5k-26.9%

How much money is BioForce Nanosciences Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$118.1k-$58.7k-$59.4k-50.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of BioForce Nanosciences Holdings Inc (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  


Richest
#478 / 492

Most Revenue
#492 / 492

Most Profit
#363 / 492

Most Efficient
#347 / 492

What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc? (5 min.)

Welcome investor! BioForce Nanosciences Holdings Inc's management wants to use your money to grow the business. In return you get a share of BioForce Nanosciences Holdings Inc.

What can you expect buying and holding a share of BioForce Nanosciences Holdings Inc?

First you should know what it really means to hold a share of BioForce Nanosciences Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of BioForce Nanosciences Holdings Inc is $1.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioForce Nanosciences Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioForce Nanosciences Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.07. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioForce Nanosciences Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.4%0.00-0.4%0.00-0.4%-0.27-24.9%-0.15-13.8%
Usd Book Value Change Per Share0.00-0.4%0.00-0.4%0.00-0.4%0.00-0.3%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.4%0.00-0.4%0.00-0.4%0.00-0.3%0.00-0.2%
Usd Price Per Share1.70-1.75-2.27-1.41-0.98-
Price to Earnings Ratio-95.10--108.99--139.26--161.80--252.84-
Price-to-Total Gains Ratio-380.41--435.97--557.20--257.97--150.55-
Price to Book Ratio-25.52--29.07--53.79-154.78-600.59-
Price-to-Total Gains Ratio-380.41--435.97--557.20--257.97--150.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1
Number of shares909
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (909 shares)-3.67-3.08
Gains per Year (909 shares)-14.68-12.32
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-15-250-12-22
20-29-400-25-34
30-44-550-37-46
40-59-700-49-58
50-73-850-62-70
60-88-1000-74-82
70-103-1150-86-94
80-117-1300-99-106
90-132-1450-111-118
100-147-1600-123-130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.034.00.05.6%2.045.00.04.3%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%7.028.01.019.4%9.037.01.019.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.036.00.0%4.00.043.08.5%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%7.028.01.019.4%9.037.01.019.1%

Fundamentals of BioForce Nanosciences Holdings Inc

About BioForce Nanosciences Holdings Inc

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online under the BioForce Eclipse brand, as well as through social media and telemarketing. BioForce Nanosciences Holdings, Inc. was incorporated in 1999 and is based in Virginia Beach, Virginia.

Fundamental data was last updated by Penke on 2024-05-14 14:32:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BioForce Nanosciences Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BioForce Nanosciences Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.7%+5.7%
5Y-5.7%10Y-69.6%+63.9%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.4%-3.4%
TTM-3.0%-3.0%
YOY-2.8%-2.8%
5Y-5.7%3.3%-9.0%
10Y-69.6%3.6%-73.2%
1.1.2. Return on Assets

Shows how efficient BioForce Nanosciences Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • -20,439.5% Return on Assets means that BioForce Nanosciences Holdings Inc generated $-204.40 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is -20,439.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18,088.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20,439.5%TTM-18,088.4%-2,351.1%
TTM-18,088.4%YOY-4,592.1%-13,496.3%
TTM-18,088.4%5Y-20,147.8%+2,059.4%
5Y-20,147.8%10Y-11,208.5%-8,939.3%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-20,439.5%1.2%-20,440.7%
TTM-18,088.4%1.1%-18,089.5%
YOY-4,592.1%1.0%-4,593.1%
5Y-20,147.8%1.2%-20,149.0%
10Y-11,208.5%1.3%-11,209.8%
1.1.3. Return on Equity

Shows how efficient BioForce Nanosciences Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • 0.0% Return on Equity means BioForce Nanosciences Holdings Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-108,414.5%+108,414.5%
5Y-108,414.5%10Y-60,258.0%-48,156.5%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.4%-2.4%
TTM-2.3%-2.3%
YOY-2.2%-2.2%
5Y-108,414.5%2.4%-108,416.9%
10Y-60,258.0%2.6%-60,260.6%

1.2. Operating Efficiency of BioForce Nanosciences Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BioForce Nanosciences Holdings Inc is operating .

  • Measures how much profit BioForce Nanosciences Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5.7%+5.7%
5Y-5.7%10Y-64.6%+59.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.4%-5.4%
TTM-3.0%-3.0%
YOY-4.4%-4.4%
5Y-5.7%4.8%-10.5%
10Y-64.6%4.9%-69.5%
1.2.2. Operating Ratio

Measures how efficient BioForce Nanosciences Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.119-0.119
5Y0.11910Y0.980-0.861
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.548-1.548
TTM-1.462-1.462
YOY-1.357-1.357
5Y0.1191.315-1.196
10Y0.9801.196-0.216

1.3. Liquidity of BioForce Nanosciences Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.000. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.000TTM0.0000.000
TTM0.000YOY0.002-0.002
TTM0.0005Y1.397-1.396
5Y1.39710Y11.568-10.172
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0001.556-1.556
TTM0.0001.563-1.563
YOY0.0021.620-1.618
5Y1.3971.658-0.261
10Y11.5681.614+9.954
1.3.2. Quick Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.0000.000
TTM0.000YOY0.002-0.002
TTM0.0005Y1.365-1.365
5Y1.36510Y10.015-8.651
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.547-0.547
TTM0.0000.573-0.573
YOY0.0020.621-0.619
5Y1.3650.700+0.665
10Y10.0150.734+9.281

1.4. Solvency of BioForce Nanosciences Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BioForce Nanosciences Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BioForce Nanosciences Holdings Inc to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 3,047.94 means that BioForce Nanosciences Holdings Inc assets are financed with 304,794.2% credit (debt) and the remaining percentage (100% - 304,794.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 3,047.942. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2,705.152. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3,047.942TTM2,705.152+342.790
TTM2,705.152YOY1,439.164+1,265.988
TTM2,705.1525Y841.842+1,863.310
5Y841.84210Y467.753+374.089
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ3,047.9420.476+3,047.466
TTM2,705.1520.488+2,704.664
YOY1,439.1640.483+1,438.681
5Y841.8420.481+841.361
10Y467.7530.488+467.265
1.4.2. Debt to Equity Ratio

Measures if BioForce Nanosciences Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioForce Nanosciences Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.325-0.325
5Y0.32510Y0.302+0.023
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.909-0.909
TTM-0.950-0.950
YOY-0.946-0.946
5Y0.3250.991-0.666
10Y0.3021.049-0.747

2. Market Valuation of BioForce Nanosciences Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings BioForce Nanosciences Holdings Inc generates.

  • Above 15 is considered overpriced but always compare BioForce Nanosciences Holdings Inc to the Packaged Foods industry mean.
  • A PE ratio of -95.10 means the investor is paying $-95.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -61.536. Based on the earnings, the company is expensive. -2
  • The MRQ is -95.102. Based on the earnings, the company is expensive. -2
  • The TTM is -108.992. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-61.536MRQ-95.102+33.565
MRQ-95.102TTM-108.992+13.891
TTM-108.992YOY-139.260+30.268
TTM-108.9925Y-161.797+52.805
5Y-161.79710Y-252.838+91.040
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-61.53614.237-75.773
MRQ-95.10213.166-108.268
TTM-108.99212.751-121.743
YOY-139.26013.387-152.647
5Y-161.79716.632-178.429
10Y-252.83819.595-272.433
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -457.866. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -707.611. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1,430.210. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-457.866MRQ-707.611+249.745
MRQ-707.611TTM-1,430.210+722.599
TTM-1,430.210YOY-1,362.343-67.867
TTM-1,430.2105Y-998.610-431.601
5Y-998.61010Y-744.465-254.144
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-457.8664.049-461.915
MRQ-707.6113.670-711.281
TTM-1,430.2102.504-1,432.714
YOY-1,362.3430.357-1,362.700
5Y-998.6101.652-1,000.262
10Y-744.4651.287-745.752
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BioForce Nanosciences Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of -25.52 means the investor is paying $-25.52 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioForce Nanosciences Holdings Inc:

  • The EOD is -16.512. Based on the equity, the company is expensive. -2
  • The MRQ is -25.518. Based on the equity, the company is expensive. -2
  • The TTM is -29.075. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.512MRQ-25.518+9.007
MRQ-25.518TTM-29.075+3.556
TTM-29.075YOY-53.792+24.717
TTM-29.0755Y154.776-183.851
5Y154.77610Y600.594-445.818
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-16.5121.492-18.004
MRQ-25.5181.498-27.016
TTM-29.0751.457-30.532
YOY-53.7921.684-55.476
5Y154.7761.902+152.874
10Y600.5942.437+598.157
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioForce Nanosciences Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.004-10%-0.004-8%-0.003-24%-0.002-58%
Book Value Per Share---0.067-0.060-9%-0.044-34%-0.028-58%-0.015-77%
Current Ratio--0.0000.000-12%0.002-87%1.397-100%11.568-100%
Debt To Asset Ratio--3047.9422705.152+13%1439.164+112%841.842+262%467.753+552%
Debt To Equity Ratio----0%-0%0.325-100%0.302-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.004-0.004-10%-0.004-8%-0.273+6017%-0.152+3300%
Free Cash Flow Per Share---0.0010.000-41%0.000-17%-0.001-13%0.000-38%
Free Cash Flow To Equity Per Share--0.0000.000+675%0.000+130338%0.000+86300%0.000+17282%
Gross Profit Margin--1.0001.0000%1.0000%1.017-2%1.010-1%
Intrinsic Value_10Y_max--0.011--------
Intrinsic Value_10Y_min--0.008--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max---0.003--------
Intrinsic Value_3Y_min---0.003--------
Intrinsic Value_5Y_max---0.001--------
Intrinsic Value_5Y_min---0.001--------
Market Cap32198980.000-55%49762060.00051298829.500-3%66520165.500-25%41243966.200+21%31403981.545+58%
Net Profit Margin----0%-0%-0.0570%-0.6960%
Operating Margin----0%-0%-0.0570%-0.6460%
Operating Ratio----0%-0%0.119-100%0.980-100%
Pb Ratio-16.512+35%-25.518-29.075+14%-53.792+111%154.776-116%600.594-104%
Pe Ratio-61.536+35%-95.102-108.992+15%-139.260+46%-161.797+70%-252.838+166%
Price Per Share1.100-55%1.7001.753-3%2.273-25%1.409+21%0.983+73%
Price To Free Cash Flow Ratio-457.866+35%-707.611-1430.210+102%-1362.343+93%-998.610+41%-744.465+5%
Price To Total Gains Ratio-246.145+35%-380.406-435.969+15%-557.203+46%-257.966-32%-150.549-60%
Quick Ratio---0.000-100%0.002-100%1.365-100%10.015-100%
Return On Assets---204.395-180.884-12%-45.921-78%-201.478-1%-112.085-45%
Return On Equity----0%-0%-1084.1450%-602.5800%
Total Gains Per Share---0.004-0.004-10%-0.004-8%-0.003-24%-0.002-58%
Usd Book Value---1950043.000-1766326.500-9%-1291789.000-34%-826692.550-58%-451529.417-77%
Usd Book Value Change Per Share---0.004-0.004-10%-0.004-8%-0.003-24%-0.002-58%
Usd Book Value Per Share---0.067-0.060-9%-0.044-34%-0.028-58%-0.015-77%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.004-0.004-10%-0.004-8%-0.273+6017%-0.152+3300%
Usd Free Cash Flow---17581.000-10307.250-41%-14625.500-17%-15379.400-13%-10474.556-40%
Usd Free Cash Flow Per Share---0.0010.000-41%0.000-17%-0.001-13%0.000-38%
Usd Free Cash Flow To Equity Per Share--0.0000.000+675%0.000+130338%0.000+86300%0.000+17282%
Usd Market Cap32198980.000-55%49762060.00051298829.500-3%66520165.500-25%41243966.200+21%31403981.545+58%
Usd Price Per Share1.100-55%1.7001.753-3%2.273-25%1.409+21%0.983+73%
Usd Profit---130813.000-118190.250-10%-58729.750-55%-7989214.200+6007%-4441930.139+3296%
Usd Revenue----0%-0%-292.5000%855.806-100%
Usd Total Gains Per Share---0.004-0.004-10%-0.004-8%-0.003-24%-0.002-58%
 EOD+2 -6MRQTTM+4 -23YOY+4 -235Y+11 -1910Y+11 -20

3.2. Fundamental Score

Let's check the fundamental score of BioForce Nanosciences Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-61.536
Price to Book Ratio (EOD)Between0-1-16.512
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than13,047.942
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-204.395
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of BioForce Nanosciences Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.670
Ma 20Greater thanMa 501.391
Ma 50Greater thanMa 1001.588
Ma 100Greater thanMa 2001.737
OpenGreater thanClose1.010
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1
Total Liabilities1,951
Total Stockholder Equity-1,950
 As reported
Total Liabilities 1,951
Total Stockholder Equity+ -1,950
Total Assets = 1

Assets

Total Assets1
Total Current Assets1
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 1
Total Current Assets  (as reported)1
Total Current Assets  (calculated)1
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,951
Long-term Liabilities0
Total Stockholder Equity-1,950
Total Current Liabilities
Accounts payable 10
Total Current Liabilities  (as reported)1,951
Total Current Liabilities  (calculated)10
+/- 1,941
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-1,950
Total Stockholder Equity (calculated)0
+/- 1,950
Other
Capital Stock29
Common Stock Shares Outstanding 29,272
Net Invested Capital -1,950
Net Working Capital -1,950



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-09-302006-06-302006-03-312005-09-302005-06-30
> Total Assets 
0
0
6,500
5,936
5,390
5,061
3,529
3,192
3,091
2,579
2,306
2,197
21
21
20
20
19
18
18
18
16
16
15
15
14
13
12
21
21
24
29
35
41
47
53
59
51
43
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
111111191111272732404043515953474135292421211213141515161618181819202021212,1972,3062,5793,0913,1923,5295,0615,3905,9366,50000
   > Total Current Assets 
0
0
5,433
4,864
4,247
3,874
2,119
1,790
1,775
1,256
1,058
1,127
21
21
20
20
19
18
18
18
16
16
15
15
14
13
12
21
21
24
29
35
41
47
53
59
51
43
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
111111191111272732404043515953474135292421211213141515161618181819202021211,1271,0581,2561,7751,7902,1193,8744,2474,8645,43300
       Cash And Cash Equivalents 
0
0
5,356
4,467
3,631
2,603
762
552
269
58
56
12
21
21
20
20
19
0
18
18
16
16
15
14
14
13
12
14
14
24
24
29
35
41
47
53
47
40
40
40
32
27
27
11
11
9
1
1
1
1
1
1
1
11111119111127273240404047534741352924241414121314141516161818019202021211256582695527622,6033,6314,4675,35600
       Net Receivables 
0
0
16
14
9
22
272
6
314
207
128
269
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
0
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000666660550000000000000002691282073146272229141600
       Other Current Assets 
0
0
6
66
48
55
116
102
146
91
55
77
21
0
0
20
0
18
0
18
0
0
0
15
14
13
0
2
2
0
0
0
0
0
0
6
5
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000356000000220131415000180180200021775591146102116554866600
   > Long-term Assets 
0
0
1,068
1,072
1,142
1,187
1,410
1,403
1,316
1,322
1,248
1,070
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000001,0701,2481,3221,3161,4031,4101,1871,1421,0721,06800
       Property Plant Equipment 
0
0
555
524
549
538
695
638
584
546
465
375
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000037546554658463869553854952455500
       Intangible Assets 
0
0
513
548
593
649
715
764
732
777
783
675
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000067578377773276471564959354851300
> Total Liabilities 
41
43
45
603
621
1,119
1,009
1,051
858
917
1,331
1,703
0
0
0
1
1
1
1
1
1
1
1
-1
1
1
1
13
13
8
5
5
7
5
5
12
44
162
277
400
537
655
769
873
1,005
1,119
1,233
1,348
1,478
1,592
1,706
1,820
1,951
1,9511,8201,7061,5921,4781,3481,2331,1191,00587376965553740027716244125575581313111-1111111110001,7031,3319178581,0511,0091,119621603454341
   > Total Current Liabilities 
41
43
45
171
226
840
798
891
703
774
1,193
1,588
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
13
13
8
5
5
7
5
5
12
44
162
277
400
537
655
769
873
1,005
1,119
1,233
1,348
1,478
1,592
1,706
1,820
1,951
1,9511,8201,7061,5921,4781,3481,2331,1191,005873769655537400277162441255755813131111111111110001,5881,193774703891798840226171454341
       Short-term Debt 
0
0
0
0
26
132
238
109
89
73
296
719
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
34
47
56
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000005647340000000001111000000000007192967389109238132260000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
34
47
56
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000564734000000000111100000000000000000000000
       Accounts payable 
4
3
41
163
200
506
247
318
305
418
543
506
0
0
0
1
0
1
1
1
1
1
1
1
1
1
1
13
13
8
5
5
7
5
5
10
1
0
0
5
12
1
0
6
0
0
1
0
2
1
1
3
10
10311201006011250011055755813131111111111010005065434183053182475062001634134
       Other Current Liabilities 
38
39
4
8
0
193
257
422
255
246
311
331
0
0
0
0
1
-1
0
0
0
0
0
0
-1
-1
0
0
13
8
0
5
7
5
5
1
10
115
221
395
525
654
768
867
1,005
1,119
1,232
1,348
1,476
1,591
1,704
0
0
001,7041,5911,4761,3481,2321,1191,0058677686545253952211151015575081300-1-1000000-1100003313112462554222571930843938
   > Long-term Liabilities 
0
0
444
433
395
279
211
159
155
144
138
115
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
00002010000000000000000000000-10000000000011513814415515921127939543344400
> Total Stockholder Equity
-41
-43
-45
5,333
4,769
3,942
2,520
2,142
2,233
1,661
975
495
21
20
20
19
19
36
17
17
16
15
15
-21
-63
-423
12
8
8
16
24
30
34
42
48
47
7
-119
-237
-360
-505
-627
-741
-862
-994
-1,110
-1,233
-1,347
-1,477
-1,591
-1,705
-1,819
-1,950
-1,950-1,819-1,705-1,591-1,477-1,347-1,233-1,110-994-862-741-627-505-360-237-1197474842343024168812-423-63-2115151617173619192020214959751,6612,2332,1422,5203,9424,7695,333-45-43-41
   Common Stock
2
2
4
24
24
24
24
24
25
25
25
25
0
0
0
0
0
0
0
0
0
36
36
76
76
76
76
76
76
76
76
76
76
76
76
15
15
15
15
29
29
29
29
29
29
29
29
29
29
29
29
0
0
00292929292929292929292929151515157676767676767676767676763636000000000252525252424242424422
   Retained Earnings 
-376
-378
-380
0
-8,600
-9,907
-11,915
-13,548
-14,135
-14,891
-15,815
-16,506
21
20
20
0
0
0
0
0
0
-21
-21
-21
-63
-423
-447
-647
-647
-700
-707
-715
-728
-735
-742
-762
-158,803
-158,930
-159,048
-159,170
-159,315
-159,438
-159,552
-159,672
-159,805
-159,920
-160,043
-160,158
-160,288
-160,402
-160,515
-160,630
-160,761
-160,761-160,630-160,515-160,402-160,288-160,158-160,043-159,920-159,805-159,672-159,552-159,438-159,315-159,170-159,048-158,930-158,803-762-742-735-728-715-707-700-647-647-447-423-63-21-21-21000000202021-16,506-15,815-14,891-14,135-13,548-11,915-9,907-8,6000-380-378-376
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
158,781
0
158,781
158,781
0
0
0
0
0
0
000000158,781158,7810158,7810000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
332
333
332
5,887
13,966
14,494
14,668
16,492
17,231
16,531
16,784
16,999
0
0
0
19
19
36
17
17
16
0
0
-76
0
0
383
0
579
640
654
669
686
701
714
794
158,793
158,793
158,793
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
158,781
0
0
00158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,781158,793158,793158,793794714701686669654640579038300-760016171736191900016,99916,78416,53117,23116,49214,66814,49413,9665,887332333332



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.